Author Archives: Mark Senak

Weekly Roundup 9.7.18

BAM!  Traffic has returned. So have we all from the beach or the mountains or somewhere in between. Back-to and First-Day-of-school pictures have dominated Facebook postings. A promise has been extended by weather folks that the high  temperatures and humidity … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 9.7.18

Weekly Roundup 8.24.18

This is it. We are in the home stretch. Summer, at least the one defined by the school year, is almost over.  Even though it is many years for me that I have been ruled by that calendar, it will … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 8.24.18

Mid-Year Check on the Pace of New Drug Approvals at FDA

At the mid-year point, I usually do a check-in to see how we are doing on new drug approvals and how it compares to years gone by. I am quite tardy checking in on that front, so let’s get it … Continue reading

Posted in FDA Policy | Comments Off on Mid-Year Check on the Pace of New Drug Approvals at FDA

Weekly Roundup 8.17.18

The vacation continues here in Washington, D.C. Traffic is lighter than a feather. Heat and thunderstorms continue and some of the leaves on trees have had it and are falling early, not in autumnal fashion, but as dried up little … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 8.17.18

Weekly Roundup 8.10.18

The summer creaks onward. In less than a month it will be Labor Day. I don’t know about you, but I find that almost incomprehensible. The folks on Capitol Hill are gone, which makes traffic here almost bearable. We like … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 8.10.18